Alitretinoin

Toctino

10 MG CapsuleCanadaCancelledAuthorised 11 Jan 2011

This page is kept for reference and is not offered to search engines.

In other countries

The same active substances on other registers, the same brand first.

TOCTINO 10 mg CAPSULAS BLANDASSpain · 10 mg · cápsula blanda · Glaxosmithkline S.A.Same brand
TOCTINO 30 mg CAPSULAS BLANDASSpain · 30 mg · cápsula blanda · Glaxosmithkline S.A.Same brand
ToctinoItaly · Capsula molle · Stiefel Laboratories Legacy (Ireland) LTDSame brand
Toctino 10 mg, capsules, zachtNetherlands · Capsule, zacht · Stiefel Laboratories Legacy (Ireland) Limited, Unit 2Same brand
Toctino 30 mg, capsules, zachtNetherlands · Capsule, zacht · Stiefel Laboratories Legacy (Ireland) Limited, Unit 2Same brand

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Alitretinoin

Toctino

10 MG CapsuleCanadaCancelledAuthorised 11 Jan 2011

Open in the registerAsk Osler about it

This page is kept for reference and is not offered to search engines.

In other countries

The same active substances on other registers, the same brand first.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Alitretinoina Ifc 10 MG Capsulas Blandas EfgSpain · 10 mg · cápsula blanda · Industrial Farmaceutica Cantabria S.A.

AlitrecareItaly · Capsula molle · Difa Cooper S.P.A.

Alipalmtin 10 mg zachte capsulesNetherlands · Capsule, zacht · Orifarm Healthcare A/S

PanretinEuropean Union · Eisai GmbH

PanretinUnited States · 0.1% BASE · gel · Advanz Pharma

Documents

The official texts, at the regulator.

Register entryHealth Canada

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Health Canada, Canada

Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.

Licence: Open Government Licence Canada · Added 13 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Alitretinoin
Strength: 10 MG
Dosage form: Capsule
Route: Oral
Register: Canada (Health Canada)
Status: Cancelled
Status in the register: Cancelled Post Market
Authorised: 11 Jan 2011
Registration: DIN 02337630
Marketing authorisation holder: Glaxosmithkline INC
ATC code: D11AH04
Group: Dermatologicals
Supply: PRESCRIPTION

Health Canada

PanretinAlitretinoin · 0.1 % · GelCanadaCancelled

ToctinoAlitretinoin · 30 MG · CapsuleCanadaCancelled